Protagonist Therapeutics (PTGX) Other Non Operating Income (2017 - 2025)
Historic Other Non Operating Income for Protagonist Therapeutics (PTGX) over the last 8 years, with Q3 2025 value amounting to $33000.0.
- Protagonist Therapeutics' Other Non Operating Income fell 7659.57% to $33000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $182000.0, marking a year-over-year decrease of 3079.85%. This contributed to the annual value of $250000.0 for FY2024, which is 22437.81% up from last year.
- As of Q3 2025, Protagonist Therapeutics' Other Non Operating Income stood at $33000.0, which was down 7659.57% from $36000.0 recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Other Non Operating Income ranged from a high of $141000.0 in Q3 2024 and a low of -$195000.0 during Q1 2023
- Moreover, its 5-year median value for Other Non Operating Income was $0.0 (2021), whereas its average is -$1611.1.
- Per our database at Business Quant, Protagonist Therapeutics' Other Non Operating Income surged by 64615.38% in 2022 and then crashed by 160000.0% in 2023.
- Over the past 5 years, Protagonist Therapeutics' Other Non Operating Income (Quarter) stood at -$13000.0 in 2021, then surged by 646.15% to $71000.0 in 2022, then plummeted by 38.03% to $44000.0 in 2023, then fell by 29.55% to $31000.0 in 2024, then rose by 6.45% to $33000.0 in 2025.
- Its Other Non Operating Income stands at $33000.0 for Q3 2025, versus $36000.0 for Q2 2025 and $82000.0 for Q1 2025.